JPS57112334A - Particles of lipid soluble substance, composition consisting of particles and biologically active substance adsorbed with particles and their manufacture - Google Patents
Particles of lipid soluble substance, composition consisting of particles and biologically active substance adsorbed with particles and their manufactureInfo
- Publication number
- JPS57112334A JPS57112334A JP55184157A JP18415780A JPS57112334A JP S57112334 A JPS57112334 A JP S57112334A JP 55184157 A JP55184157 A JP 55184157A JP 18415780 A JP18415780 A JP 18415780A JP S57112334 A JPS57112334 A JP S57112334A
- Authority
- JP
- Japan
- Prior art keywords
- particles
- manufacture
- biologically active
- composition consisting
- lipid soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/586—Liposomes, microcapsules or cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Public Health (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- External Artificial Organs (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU79HU299A HU184141B (en) | 1979-12-27 | 1979-12-27 | Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57112334A true JPS57112334A (en) | 1982-07-13 |
JPH0314814B2 JPH0314814B2 (ja) | 1991-02-27 |
Family
ID=10997378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP55184157A Granted JPS57112334A (en) | 1979-12-27 | 1980-12-26 | Particles of lipid soluble substance, composition consisting of particles and biologically active substance adsorbed with particles and their manufacture |
Country Status (21)
Country | Link |
---|---|
US (1) | US4396630A (ja) |
JP (1) | JPS57112334A (ja) |
BE (1) | BE886884A (ja) |
CA (1) | CA1165237A (ja) |
CH (1) | CH655246A5 (ja) |
CS (1) | CS241478B2 (ja) |
DD (1) | DD158738A5 (ja) |
DE (1) | DE3048815A1 (ja) |
DK (1) | DK160288C (ja) |
ES (1) | ES8201316A1 (ja) |
FR (1) | FR2472386B1 (ja) |
GB (1) | GB2066203B (ja) |
HU (1) | HU184141B (ja) |
IT (1) | IT1150073B (ja) |
NL (1) | NL8007041A (ja) |
PL (1) | PL228755A1 (ja) |
PT (1) | PT72261B (ja) |
RO (1) | RO81371A (ja) |
SE (1) | SE453537B (ja) |
SU (1) | SU1487802A3 (ja) |
YU (1) | YU44413B (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03218465A (ja) * | 1989-11-17 | 1991-09-26 | Sekisui Chem Co Ltd | 梅毒診断試薬の製造方法 |
WO1992004887A1 (en) * | 1990-09-25 | 1992-04-02 | Kyowa Hakko Kogyo Co., Ltd. | Induction of cytotoxic t cell |
WO2006090816A1 (ja) * | 2005-02-25 | 2006-08-31 | Mie University | リポソームワクチンの作製法 |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4598051A (en) * | 1980-03-12 | 1986-07-01 | The Regents Of The University Of California | Liposome conjugates and diagnostic methods therewith |
US4806466A (en) * | 1981-10-29 | 1989-02-21 | The Regents Of The University Of California | Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes |
FR2521565B1 (fr) * | 1982-02-17 | 1985-07-05 | Dior Sa Parfums Christian | Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees |
WO1987002576A1 (en) * | 1985-10-31 | 1987-05-07 | Kv Pharmaceutical Company | Vaginal delivery systems |
DD247570A3 (de) * | 1983-01-14 | 1987-07-15 | Univ Berlin Humboldt | Vesikulaeres trenn-, fuell- und traegermaterial |
US4515736A (en) * | 1983-05-12 | 1985-05-07 | The Regents Of The University Of California | Method for encapsulating materials into liposomes |
US5059591B1 (en) * | 1983-05-26 | 2000-04-25 | Liposome Co Inc | Drug preparations of reduced toxicity |
US4708861A (en) * | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
US5916588A (en) * | 1984-04-12 | 1999-06-29 | The Liposome Company, Inc. | Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use |
US6090406A (en) * | 1984-04-12 | 2000-07-18 | The Liposome Company, Inc. | Potentiation of immune responses with liposomal adjuvants |
GB2160312B (en) * | 1984-04-13 | 1987-09-16 | South African Inventions | Adjuvant for immunisation |
PT78628B (en) * | 1984-05-02 | 1986-06-18 | Liposome Co Inc | Pharmaceutical composition with reduced toxicity |
US4619904A (en) * | 1984-10-29 | 1986-10-28 | General Electric Company | Agglutinating immunoassay using protein-coated liquid droplets |
US4857319A (en) * | 1985-01-11 | 1989-08-15 | The Regents Of The University Of California | Method for preserving liposomes |
US5266329A (en) * | 1985-10-31 | 1993-11-30 | Kv Pharmaceutical Company | Vaginal delivery system |
US4790987A (en) * | 1985-11-15 | 1988-12-13 | Research Corporation | Viral glycoprotein subunit vaccine |
CA1338736C (fr) * | 1986-12-05 | 1996-11-26 | Roger Baurain | Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation |
US4748024A (en) * | 1987-04-06 | 1988-05-31 | Endocon, Inc. | Flash flow fused medicinal implants |
US5688519A (en) * | 1987-04-06 | 1997-11-18 | Leonard; Robert J. | Flash-flow fused medicinal implants |
WO1990001947A1 (en) * | 1988-08-25 | 1990-03-08 | The Liposome Company, Inc. | Affinity associated vaccine |
EP0374296B1 (en) * | 1988-12-22 | 1995-02-01 | Dade International Inc. | Lipohaptens and use of carrier-bound lipohaptens in immunoassays |
US5100662A (en) * | 1989-08-23 | 1992-03-31 | The Liposome Company, Inc. | Steroidal liposomes exhibiting enhanced stability |
NL9000207A (ja) * | 1990-01-29 | 1991-08-16 | Duphar Int Res | |
CA2086094C (en) * | 1990-06-29 | 2000-05-30 | Gail L. Barchfeld | Vaccine compositions containing liposomes |
US5709879A (en) * | 1990-06-29 | 1998-01-20 | Chiron Corporation | Vaccine compositions containing liposomes |
IE912535A1 (en) * | 1990-07-27 | 1992-01-29 | Res Dev Foundation | Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens |
US6048531A (en) * | 1991-04-15 | 2000-04-11 | Albany Medical College | Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies |
US5336507A (en) * | 1992-12-11 | 1994-08-09 | Sterling Winthrop Inc. | Use of charged phospholipids to reduce nanoparticle aggregation |
GB9320668D0 (en) | 1993-10-07 | 1993-11-24 | Secr Defence | Liposomes containing particulare materials |
AUPM500494A0 (en) * | 1994-04-12 | 1994-05-05 | Minister For Agriculture & Rural Affairs For The State Of New South Wales, The | Composition for use in increasing mucosal immunity |
NZ525552A (en) * | 2000-11-09 | 2005-04-29 | Neopharm Inc | SN-38 lipid complexes with cardiolipin and methods of use for the treatment of cancers and multiple sclerosis |
WO2003030864A1 (en) * | 2001-05-29 | 2003-04-17 | Neopharm, Inc. | Liposomal formulation of irinotecan |
CA2477979A1 (en) * | 2002-03-05 | 2003-09-18 | Transave, Inc. | An inhalation system for treatment of intracellular infections |
US20060030578A1 (en) * | 2002-08-20 | 2006-02-09 | Neopharm, Inc. | Pharmaceutically active lipid based formulation of irinotecan |
WO2004035032A2 (en) * | 2002-08-20 | 2004-04-29 | Neopharm, Inc. | Pharmaceutical formulations of camptothecine derivatives |
US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
MXPA05004580A (es) * | 2002-10-29 | 2005-07-26 | Transave Inc | Liberacion sostenida de anti - infecciosos. |
US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
KR100651728B1 (ko) * | 2004-11-10 | 2006-12-06 | 한국전자통신연구원 | 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법 |
PL1962805T3 (pl) | 2005-12-08 | 2017-01-31 | Insmed Incorporated | Kompozycje środków przeciwzapalnych oparte na lipidach do leczenia infekcji płucnych |
WO2008137717A1 (en) | 2007-05-04 | 2008-11-13 | Transave, Inc. | Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof |
US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
KR102277921B1 (ko) | 2012-05-21 | 2021-07-14 | 인스메드 인코포레이티드 | 폐 감염을 치료하기 위한 시스템 |
CA2891487A1 (en) | 2012-11-29 | 2014-06-05 | Insmed Incorporated | Stabilized vancomycin formulations |
PL3142643T3 (pl) | 2014-05-15 | 2019-12-31 | Insmed Incorporated | Sposoby leczenia zakażeń płuc prątkami niegruźliczymi |
WO2019191627A1 (en) | 2018-03-30 | 2019-10-03 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5126218A (en) * | 1974-06-25 | 1976-03-04 | Nat Res Dev | Menekikatsuseizaino seiho |
JPS52143218A (en) * | 1976-03-19 | 1977-11-29 | Ici Ltd | Pharmaceutical composition |
JPS53142514A (en) * | 1977-05-10 | 1978-12-12 | Ici Ltd | Freeze dried latent liposome mixture * aqueous liposome preparation and production thereof |
JPS55118415A (en) * | 1979-02-28 | 1980-09-11 | Pii Papahadojiyopo Dometoriosu | Method of encapsulating biologically active substance in lipoid cell |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3265629A (en) * | 1958-12-22 | 1966-08-09 | Ncr Co | Coating by phase separation |
DE2249552A1 (de) * | 1971-10-12 | 1973-05-30 | Inchema S A | Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen |
JPS5126213A (ja) * | 1974-08-21 | 1976-03-04 | Tanabe Seiyaku Co | Johoseibiryushiseizaino seiho |
GB1564500A (en) * | 1975-09-29 | 1980-04-10 | Wellcome Found | Biological preparations |
IT1110989B (it) * | 1979-01-19 | 1986-01-13 | Erba Farmitalia | Forme farmaceutiche costitutite da liposomi e procedimenti relativi |
FR2416008A1 (fr) * | 1978-02-02 | 1979-08-31 | Oreal | Lyophilisats de liposomes |
US4235871A (en) * | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
-
1979
- 1979-12-27 HU HU79HU299A patent/HU184141B/hu unknown
-
1980
- 1980-12-12 CH CH9166/80A patent/CH655246A5/de not_active IP Right Cessation
- 1980-12-19 US US06/218,126 patent/US4396630A/en not_active Expired - Fee Related
- 1980-12-22 PT PT72261A patent/PT72261B/pt unknown
- 1980-12-22 SE SE8009068A patent/SE453537B/sv not_active IP Right Cessation
- 1980-12-22 ES ES80498048A patent/ES8201316A1/es not_active Expired
- 1980-12-23 GB GB804281A patent/GB2066203B/en not_active Expired
- 1980-12-23 DK DK552280A patent/DK160288C/da active
- 1980-12-23 PL PL22875580A patent/PL228755A1/xx unknown
- 1980-12-23 DE DE19803048815 patent/DE3048815A1/de active Granted
- 1980-12-23 CS CS809246A patent/CS241478B2/cs unknown
- 1980-12-24 FR FR8027496A patent/FR2472386B1/fr not_active Expired
- 1980-12-24 CA CA000367565A patent/CA1165237A/en not_active Expired
- 1980-12-24 NL NL8007041A patent/NL8007041A/nl not_active Application Discontinuation
- 1980-12-24 IT IT26950/80A patent/IT1150073B/it active
- 1980-12-25 RO RO80102952A patent/RO81371A/ro unknown
- 1980-12-26 SU SU803220898A patent/SU1487802A3/ru active
- 1980-12-26 JP JP55184157A patent/JPS57112334A/ja active Granted
- 1980-12-26 YU YU3290/80A patent/YU44413B/xx unknown
- 1980-12-29 BE BE0/203337A patent/BE886884A/fr not_active IP Right Cessation
-
1981
- 1981-01-30 DD DD81227326A patent/DD158738A5/de not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5126218A (en) * | 1974-06-25 | 1976-03-04 | Nat Res Dev | Menekikatsuseizaino seiho |
JPS52143218A (en) * | 1976-03-19 | 1977-11-29 | Ici Ltd | Pharmaceutical composition |
JPS53142514A (en) * | 1977-05-10 | 1978-12-12 | Ici Ltd | Freeze dried latent liposome mixture * aqueous liposome preparation and production thereof |
JPS55118415A (en) * | 1979-02-28 | 1980-09-11 | Pii Papahadojiyopo Dometoriosu | Method of encapsulating biologically active substance in lipoid cell |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03218465A (ja) * | 1989-11-17 | 1991-09-26 | Sekisui Chem Co Ltd | 梅毒診断試薬の製造方法 |
WO1992004887A1 (en) * | 1990-09-25 | 1992-04-02 | Kyowa Hakko Kogyo Co., Ltd. | Induction of cytotoxic t cell |
WO2006090816A1 (ja) * | 2005-02-25 | 2006-08-31 | Mie University | リポソームワクチンの作製法 |
Also Published As
Publication number | Publication date |
---|---|
DE3048815A1 (de) | 1981-09-10 |
PT72261A (en) | 1981-01-01 |
DD158738A5 (de) | 1983-02-02 |
YU329080A (en) | 1984-04-30 |
SE8009068L (sv) | 1981-06-28 |
CH655246A5 (de) | 1986-04-15 |
RO81371A (ro) | 1984-04-02 |
ES498048A0 (es) | 1981-12-16 |
SU1487802A3 (ru) | 1989-06-15 |
PT72261B (en) | 1981-11-05 |
CA1165237A (en) | 1984-04-10 |
IT1150073B (it) | 1986-12-10 |
ES8201316A1 (es) | 1981-12-16 |
DK160288B (da) | 1991-02-25 |
DK552280A (da) | 1981-06-28 |
FR2472386B1 (ja) | 1985-08-23 |
GB2066203B (en) | 1984-01-11 |
BE886884A (fr) | 1981-06-29 |
YU44413B (en) | 1990-08-31 |
CS241478B2 (en) | 1986-03-13 |
DK160288C (da) | 1991-08-05 |
RO81371B (ro) | 1983-11-02 |
GB2066203A (en) | 1981-07-08 |
IT8026950A0 (it) | 1980-12-24 |
FR2472386A1 (ja) | 1981-07-03 |
PL228755A1 (ja) | 1982-02-15 |
CS924680A2 (en) | 1985-07-16 |
NL8007041A (nl) | 1981-07-16 |
US4396630A (en) | 1983-08-02 |
SE453537B (sv) | 1988-02-08 |
JPH0314814B2 (ja) | 1991-02-27 |
HU184141B (en) | 1984-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS57112334A (en) | Particles of lipid soluble substance, composition consisting of particles and biologically active substance adsorbed with particles and their manufacture | |
IL53595A (en) | Biological cells comprising pharmaceutically active substances and particles of magnetic material,their preparation and pharmaceutical compositions containing them | |
GB2046209B (en) | Encapsulation of chemically active biologically active materials and viable tissue | |
IL52119A0 (en) | Vehicle substances which are capable of covalent bonding with biologically active matter and their preparation | |
JPS55141476A (en) | 4hh3*11benzoxazine derivative*its manufacture and herbicide containing same as active substance | |
JPS55163057A (en) | Powdered fireeextinguishing substance and its preparation | |
JPS54112393A (en) | Porous carbon supporter* preparation thereof* and its application | |
GB2061903B (en) | Preparation of spherical carbon particles | |
IL56252A0 (en) | Pressure-ressistant polyurethane-polyurea particles for the encapsulation of active ingredients and process for their manufacture | |
JPS56123953A (en) | Basic ethers* their manufacture and medicinal composition containing them | |
IL59150A0 (en) | N-benzyl-imidazoles,their preparation and pharmaceutical compostions containing them | |
PT71048A (en) | Composite tipping structure for use on an air-ventilated cigarette and method of manufacturing same | |
PT76314B (en) | Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them | |
CS188269B2 (en) | Insecticide preparation and method of making the the active substances | |
HU174057B (hu) | Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva | |
JPS55100313A (en) | Drug composition and its manufacture | |
JPS533512A (en) | Method and composition for reducing amount of use of biologically active substance | |
JPS5635962A (en) | Stable lysine containing solid particulate composition and production thereof | |
JPS565465A (en) | Benzimidazole derivative* its manufacture and medicinal composition of same as active component | |
GB2031937B (en) | Powdered lipid composition and its production and use | |
JPS5661375A (en) | 1*2*44oxadiazolinee55one derivative* its manufacture and drug composition containing same | |
JPS55136296A (en) | Phosphorylhydrazine and insecticidal composition as active component of phosphorylhydrazine | |
JPS55118415A (en) | Method of encapsulating biologically active substance in lipoid cell | |
JPS567750A (en) | Oxyiminoosubstituteddcyclopropanecarboxylate esters* their manufacture* agricultural composition containing them and use as agricultural drug | |
JPS5634668A (en) | Tetrahydroqunoline derivative* its manufacture and antiarrhythmic as active component thereof |